FundedIQ
Biotechnology

OXCCU: Funding, Investors & Team (Sep 2026)

At OXCCU, we are leading the way in scientific progress, shaping the future of sustainable energy, fuel production, and the creation of chemicals and plastics. Our approach involves combining CO2 from the air with H2 from water and renewable electricity to produce environmentally friendly fuels, chemicals, and biodegradable plastics. Carbon is a highly valuable element, particularly when utilized in hydrocarbons. Our objective is to allow future generations to continue using hydrocarbon fuels without negatively impacting the climate. While renewable energy is becoming more prevalent, fossil fuels still account for a significant portion (82%) of the world's primary energy demand of 604 EJ in 2022. In order to minimize greenhouse gas emissions, we must transition to zero-emission sources within a 30-year timeframe. While some sectors, such as power, are already progressing in this direction, not all industries can easily decarbonize using renewable electricity alone. Specifically, long-distance aviation fuels and petrochemicals present challenges due to their need for high energy density and the carbon molecules required to produce a variety of everyday products. Here is where OXCCU provides a unique solution. Our cost-effective catalysts demonstrate exceptional efficiency and selectivity, converting CO2 into valuable hydrocarbons through an innovative one-step process. CO2 can be transformed into sustainable e-fuels, chemicals, and biodegradable plastics. This represents the future of truly circular technological advancement, where individuals can travel by air, use household chemicals, and purchase disposable and biodegradable plastic products without concerns about their contribution to climate change or waste disposal. The company was established in 2021 as a spinoff from the University of Oxford by co-founders Andrew Symes and Jane Jin, who were employed at IP Group and OUI respectively. The scientific foundations of the company are supported by breakthrough research published by the academic founders, Professor Peter Edwards, Dr Tiancun Xiao, and Dr Benzhen Yao, in highly reputable scientific journals.

www.oxccu.com LinkedIn Oxford, United Kingdom 11-50 employees
Biotechnology Chemical Chemical Engineering
Total raised
$54.1M
Rounds
3
Latest
Series B
Oct 2025

OXCCU has raised $54.1M across 3 funding rounds on record, the most recent a Series B of $27.9M announced in Oct 2025.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

OXCCU Company Profile and Key Stats

Total funding raised
$54.1M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Series B
$27.9M in Oct 2025
Employees
11-50
reported band
Headquarters
Oxford, United Kingdom

Latest funding round on record: Oct 2025.

OXCCU Funding Rounds

Date
Round
Amount
Series B
$27.9M
Undisclosed round
$3.5M
Series A
$22.7M

OXCCU raised $22.7M in a Series A announced in Jun 2023.

5 months later, an undisclosed round of $3.5M was announced in Nov 2023.

1.9 years later, a Series B of $27.9M was announced in Oct 2025.

OXCCU Founders and Leadership Team

Name
Role
Contact
Benzhen Yao
Founder
Jane Jin
Founder
Locked
Andrew Symes
CEO
Locked

Contact details for the OXCCU team: 2 of 3 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

OXCCU Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
5,273
$4.0M
4,289
$30M

OXCCU's latest round of $27.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like OXCCU in Biotechnology and Oxford

Companies Similar to OXCCU

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

IMU is a discovery engine mapping the immune system to advance precision medicine.

Series A $38.4M

Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…

Undisclosed round $5.4M

Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…

Undisclosed round

Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…

Pre-Seed $740k

Five is a biometric payment services company that offers thumb recognition technology for safe transactions.

Seed $6.0M

OXCCU Funding FAQs

What does OXCCU do?

At OXCCU, we are leading the way in scientific progress, shaping the future of sustainable energy, fuel production, and the creation of chemicals and plastics. Our approach involves combining CO2 from the air with H2 from water and renewable electricity to produce environmentally friendly fuels, chemicals, and biodegradable plastics. Carbon is a highly valuable element, particularly when utilized in hydrocarbons. Our objective is to allow future generations to continue using hydrocarbon fuels without negatively impacting the climate. While renewable energy is becoming more prevalent, fossil fuels still account for a significant portion (82%) of the world's primary energy demand of 604 EJ in 2022. In order to minimize greenhouse gas emissions, we must transition to zero-emission sources within a 30-year timeframe. While some sectors, such as power, are already progressing in this direction, not all industries can easily decarbonize using renewable electricity alone. Specifically, long-distance aviation fuels and petrochemicals present challenges due to their need for high energy density and the carbon molecules required to produce a variety of everyday products. Here is where OXCCU provides a unique solution. Our cost-effective catalysts demonstrate exceptional efficiency and selectivity, converting CO2 into valuable hydrocarbons through an innovative one-step process. CO2 can be transformed into sustainable e-fuels, chemicals, and biodegradable plastics. This represents the future of truly circular technological advancement, where individuals can travel by air, use household chemicals, and purchase disposable and biodegradable plastic products without concerns about their contribution to climate change or waste disposal. The company was established in 2021 as a spinoff from the University of Oxford by co-founders Andrew Symes and Jane Jin, who were employed at IP Group and OUI respectively. The scientific foundations of the company are supported by breakthrough research published by the academic founders, Professor Peter Edwards, Dr Tiancun Xiao, and Dr Benzhen Yao, in highly reputable scientific journals.

How much funding has OXCCU raised?

OXCCU has raised $54.1M across 3 rounds on record. The most recent is a Series B of $27.9M announced in Oct 2025.

When did OXCCU last raise funding?

OXCCU's most recent funding round on record is a Series B of $27.9M, announced in Oct 2025.

Who founded OXCCU?

FundedIQ lists Benzhen Yao (Founder), Jane Jin (Founder) at OXCCU.

Who is the CEO of OXCCU?

Andrew Symes is listed as CEO at OXCCU.

Where is OXCCU headquartered?

OXCCU is based in Oxford, Oxfordshire, United Kingdom.

How many employees does OXCCU have?

OXCCU is in the 11-50 employee band.

How does OXCCU's funding compare to other Biotechnology startups?

OXCCU's latest round of $27.9M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's OXCCU Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OXCCU is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.